Skip to content
healthcare.dev
Get a free key

celimax PORE SKIN CLARIFYING DAILY SUNSCREEN

NDC 87226-150, AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, cream, from ABSORBLAB Co., Ltd.

Product NDC
87226-150
Status
Listed
Labeler
ABSORBLAB Co., Ltd
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/87226-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HOMOSALATE6.8 g/50mL
  • OCTISALATE2.3 g/50mL
  • AVOBENZONE1.4 g/50mL
  • OCTOCRYLENE4.5 g/50mL
Package NDCNDC-11Package
87226-150-02872260150021 TUBE in 1 BOX (87226-150-02) / 50 mL in 1 TUBE (87226-150-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 87226-150 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/87226-150 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 87226-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.